Skip to main content

Table 3 Number of patients prescribed various ULTs

From: Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database

 

Febuxostat

Allopurinol

Benzbromarone

Topiroxostat

Probenecid

Age, n

 Total

54

31

15

6

1

 0–5 years

0

1

0

0

0

 6–11 years

6

3

1

0

0

 12–18 years

48

27

14

6

1

Sex, n

 Male

48

27

11

6

1

 Female

6

4

4

0

0

Comorbidity, n

 Kidney disease

28

12

7

4

0

 Cardiovascular disease

15

10

2

0

1

 Metabolic syndrome

18

14

6

3

1

 Down syndrome

4

1

1

0

0

  1. ULT urate-lowering therapy